Research Paper Volume 16, Issue 8 pp 7188—7216
Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer
Figure 5. Expression profile and survival situation of TPX2 in BRCA. (A–C) Differential expression levels of TPX2 in BRCA from TCGA and GEO database. (D) The mRNA expression of TPX2 in breast cancer cell lines. (E) The differential protein level of TPX2 in breast tumor and normal tissues. **P < 0.01, ***P < 0.001.